betamethasone has been researched along with dixyrazine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hallén, C; Sorbe, B | 3 |
| Hallén, C; Skåre, NG; Sorbe, B; Underskog, I | 1 |
4 trial(s) available for betamethasone and dixyrazine
| Article | Year |
|---|---|
Betamethasone-dixyrazine versus betamethasone-metoclopramide as antiemetic treatment of cisplatin-doxorubicin-induced nausea in ovarian carcinoma patients.
Topics: Activities of Daily Living; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Betamethasone; Cisplatin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Metoclopramide; Nausea; Ovarian Neoplasms; Phenothiazines; Pilot Projects; Prospective Studies; Random Allocation; Vomiting | 1991 |
Antiemetic treatment of chemotherapy-induced nausea in ovarian carcinoma patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antipsychotic Agents; Betamethasone; Cisplatin; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Female; Humans; Melphalan; Metoclopramide; Nausea; Ovarian Neoplasms; Phenothiazines; Prospective Studies; Random Allocation | 1989 |
Betamethasone-dixyrazine combination versus high-dose metoclopramide as antiemetic treatment in doxorubicin and cisplatin chemotherapy.
Topics: Antiemetics; Betamethasone; Cisplatin; Double-Blind Method; Doxorubicin; Female; Humans; Male; Metoclopramide; Middle Aged; Phenothiazines; Prospective Studies; Random Allocation; Vomiting | 1989 |
Betamethasone-dixyrazine versus metoclopramide as antiemetic treatment in cancer chemotherapy.
Topics: Antiemetics; Antineoplastic Agents; Betamethasone; Clinical Trials as Topic; Double-Blind Method; Humans; Metoclopramide; Nausea; Neoplasms; Phenothiazines; Prospective Studies; Random Allocation; Vomiting | 1988 |